Eli Lilly to buy Kelonia Therapeutics in up to $7 billion cancer immunotherapy drug deal

In this video

Share

Eli Lilly to buy Kelonia Therapeutics in up to $7 billion cancer immunotherapy drug deal

CNBC's Angelica Peebles reports the latest news on pharmaceuticals.
01:24
Mon, Apr 20 20269:24 AM EDT